Cellares, Stanford Automate HSC Manufacturing
February 4, 2026
Cellares partners Stanford to extend Cell Shuttle automation to gene‑edited hematopoietic stem cells for HIV and 19+ rare diseases.
February 4, 2026
Cellares partners Stanford to extend Cell Shuttle automation to gene‑edited hematopoietic stem cells for HIV and 19+ rare diseases.